OmniComm

Fort Lauderdale, United States Founded: 1997 • Age: 29 yrs Acquired By Anju Software
Web-based electronic data capture (EDC) and eClinical (eClinical) software and services for clinical research organizations

About OmniComm

OmniComm is a Healthcare company based in Fort Lauderdale (United States) founded in 1997, and was acquired by Anju Software in July 2019. Web-based electronic data capture (EDC) and eClinical (eClinical) software and services for clinical research organizations. The company has 46 employees. Its chief executive, as recorded, is Cornelis F Wit. Its Indian entity Omnicomm Eclinical Solutions Private Limited reported revenue of β‚Ή12.81 Cr. The company was acqui-hired. OmniComm offers products and services including eClinical Suite, Medical Affairs Suite, and Data Science Suite. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include DATATRAK, Prelude Dynamics and Cloudbyz; 1 of its 3 listed competitors has raised funding.

Company details

OmniComm Systems provides web-based electronic data capture (EDC) and eClinical (eClinical) software and services to pharmaceutical, biotechnology, and medical device organizations around the world. The companys EDC and eClinical software and service offerings (eClinical Products or eClinical Solutions) consist of TrialMaster, TrialOne, Promasys, and eClinical Suite. Its eClinical products allows clinical trial sponsors and investigative sites to collect, validate, transmit and analyze clinical study data. Its eClinical products are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. It also provides business process consulting services that focus on integrating EDC, and an array of eClinical Solutions and processes into the clinical trial process. The company operates through the delivery of EDC Software and services to clinical trial sponsors segment. Its services include hosting solutions, consulting services, customer support and training. Went public on January 17, 2003.

Key Metrics
  • Indian entity revenue
    ₹12.81 Cr

    FY 2025 · +15% YoY

  • Indian entity net profit
    ₹1.60 Cr

    FY 2025 · 12% margin

  • Indian entity EBITDA
    ₹2.21 Cr

    FY 2025 · 17% margin

  • Latest Funding Round
    $4.1M (USD), Debt – Convertible

    Jan 2000

  • Investors
  • Employee Count
    46
  • Acquired by
    Anju Software

    (Jul 2019)

Products & Services of OmniComm

OmniComm offers a comprehensive portfolio of products and services, including eClinical Suite, Medical Affairs Suite, and Data Science Suite.

eClinical Suite
Clinical Trial Software

Tools for managing and conducting clinical trials efficiently

Medical Affairs Suite
Medical Affairs Tools

Solutions for adaptive medical affairs and patient-centric capabilities

Data Science Suite
Data Analytics Software

Provides insights and analytics for clinical and medical intelligence

Funding Insights of OmniComm

  • Total Rounds 1
  • Last Round Debt – Convertible β€” $4.1M
  • First Round $4.1M

    (Jan 2000)

All 1 funding rounds of OmniComm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2000$4.1MDebt – Convertible––
–
Valuation history

1 investors in total: 1 institutional.

Investors in OmniComm

OmniComm has secured backing from 1 investor. Prominent investors backing the company include Anju Software.

All
InvestorDescriptionFounded YearDomainLocation
Life science software platform for pharmaceutical business applications.
2015anjusoftware.comNew York, United States
Premium access

Investor details for OmniComm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Omnicomm Eclinical Solutions Private Limited (OmniComm)

Omnicomm Eclinical Solutions Private Limited is the primary company behind OmniComm. The board of Omnicomm Eclinical Solutions Private Limited currently have 2 directors; the longest-serving is Mohd Akbar Khan, appointed in 2020. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mohd Akbar Khan
DIN 07094993
Director01 Jul 20206 yrs 4 moOmnicomm Eclinical Solutions Private Limited
Kailash Chand Sharma
DIN 08185285
Director01 Jul 20206 yrs 4 moOmnicomm Eclinical Solutions Private Limited

People of OmniComm

1 people are tracked at OmniComm (1 in leadership); the tracked headcount is 46.

NameRoleGroup
Cornelis F Wit
CEOLeadership
Premium access

Complete people profiles for OmniComm

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of OmniComm

Figures of Omnicomm Eclinical Solutions Private Limited, the primary company behind OmniComm, for FY 2025. Revenue was ₹12.81 Cr (+15% year on year). Net profit was ₹1.60 Cr (12% margin). EBITDA was ₹2.21 Cr (17% margin). Revenue has grown at a compounded annual rate of +12% over three years and +13% over five years.

  • ₹12.81 CrRevenue · FY 2025 · +15% YoY
  • ₹1.60 CrNet profit · 12% margin
  • ₹2.21 CrEBITDA · 17% margin
  • ₹1 LakhPaid-up capital
  • 46Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Omnicomm Eclinical Solutions Private Limited are on its company page.

Premium access

Detailed financial statements for OmniComm

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of OmniComm

3 dated milestones of OmniComm across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded OmniComm is founded.
  2. Funding First funding round of $4.1M.
  3. Exit Acquired by Anju Software.

Competitors of OmniComm

OmniComm has 3 listed competitors in our database, 1 of them funded. They include DATATRAK, Prelude Dynamics and Cloudbyz.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
datatrak.com1991Cleveland, United States$20.79M50
Cloud-based eClinical solutions for clinical trials are provided.
preludedynamics.com2004Austin, United States19
Customized web-based systems for clinical trial management are provided.
cloudbyz.com2014Chicago, United States
Delivers IT portfolio management software to optimize business technology resources.
Premium access

Detailed competitors of OmniComm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of OmniComm

Websites that share an audience with OmniComm (omnicomm.com).

Similar websites

Websites whose visitors overlap most with OmniComm. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
clinicalleader.com
100%
680.7K#948,222View details
viedoc.com
99%
21.5K#713,207View details
neuroderm.com
99%
2.8K#5,643,423View details
vblrx.com
98%
2.5K#3,978,257View details
leespharm.com
97%
#12,343,912View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for OmniComm

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as OmniComm (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Omnicomm

Premium access

Complete news archive for OmniComm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OmniComm

OmniComm was founded in 1997 and raised its 1st funding round 3 years after it was founded.

OmniComm is headquartered in Fort Lauderdale, United States. It is registered at Fort Lauderdale, Florida, United States.

Cornelis F Wit is the CEO of OmniComm, as recorded in our data.

OmniComm has 46 employees.

The primary company behind OmniComm, Omnicomm Eclinical Solutions Private Limited, reported revenue of β‚Ή12.81 Cr for FY 2025, up 15% year on year.

OmniComm Systems provides web-based electronic data capture (EDC) and eClinical (eClinical) software and services to pharmaceutical, biotechnology, and medical device organizations around the world. The companys EDC and eClinical software and service offerings (eClinical Products or eClinical Solutions) consist of TrialMaster, TrialOne, Promasys, and eClinical Suite. Its eClinical products allows clinical trial sponsors and investigative sites to collect, validate, transmit and analyze clinical study data. Its eClinical products are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. It also provides business process consulting services that focus on integrating EDC, and an array of eClinical Solutions and processes into the clinical trial process. The company operates through the delivery of EDC Software and services to clinical trial sponsors segment. Its services include hosting solutions, consulting services, customer support and training. Went public on January 17, 2003.

OmniComm's top competitors include DATATRAK, Prelude Dynamics and Cloudbyz.

OmniComm offers eClinical Suite, Medical Affairs Suite, and Data Science Suite.

OmniComm has 1 investor. Key investors include Anju Software.

OmniComm operates through Omnicomm Eclinical Solutions Private Limited.

Yes. OmniComm was acquired by Anju Software in July 2019.

The legal entities of OmniComm currently have 2 directors, including Mohd Akbar Khan, Kailash Chand Sharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available